bosentan aurobindo 125 mg filmdragerad tablett
2care4 aps - bosentanmonohydrat - filmdragerad tablett - 125 mg - bosentanmonohydrat 129,082 mg aktiv substans
bosentan aurobindo 125 mg filmdragerad tablett
medartuum ab - bosentanmonohydrat - filmdragerad tablett - 125 mg - bosentanmonohydrat 129,082 mg aktiv substans
bosentan aurobindo 62,5 mg filmdragerad tablett
medartuum ab - bosentanmonohydrat - filmdragerad tablett - 62,5 mg - bosentanmonohydrat 64,541 mg aktiv substans
bosentan aurobindo 62,5 mg filmdragerad tablett
paranova läkemedel ab - bosentanmonohydrat - filmdragerad tablett - 62,5 mg - bosentanmonohydrat 64,541 mg aktiv substans
bosentan aurobindo 125 mg filmdragerad tablett
paranova läkemedel ab - bosentanmonohydrat - filmdragerad tablett - 125 mg - bosentanmonohydrat 129,082 mg aktiv substans
bosentan aurobindo 62,5 mg filmdragerad tablett
2care4 aps - bosentanmonohydrat - filmdragerad tablett - 62,5 mg - bosentanmonohydrat 64,541 mg aktiv substans
moxifloxacin paranova 400 mg filmdragerad tablett
paranova läkemedel ab - moxifloxacinhydroklorid - filmdragerad tablett - 400 mg - moxifloxacinhydroklorid 454,75 mg aktiv substans
avelox 400 mg filmdragerad tablett
ebb medical ab - moxifloxacinhydroklorid - filmdragerad tablett - 400 mg - moxifloxacinhydroklorid 436,8 mg aktiv substans; laktosmonohydrat hjälpämne
brukinsa
beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastiska medel - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).
moxifloxacin abacus medicine 400 mg filmdragerad tablett
abacus medicine a/s - moxifloxacinhydroklorid - filmdragerad tablett - 400 mg - moxifloxacinhydroklorid 454,75 mg aktiv substans